Marianne Byrne

Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study

Behzad Hajarizadeh, Jason Grebely, Marianne Byrne et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 98 citations · Full text

Pharmacy, Preventive Medicine, Infection Prevention +11

A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study

Yumi Sheehan, Evan B. Cunningham, Amanda Cochrane et al. · Journal of Hepatology · 2023 · 53 citations

Medicine, Community Health, Infectious Disease Control +10

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

Michael Farrell, Jeyran Shahbazi, Marianne Byrne et al. · International Journal of Drug Policy · 2021 · 52 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +12

Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot

Carla Treloar, Kari Lancaster, Sandra Gendera et al. · International Journal of Drug Policy · 2022 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

Jason Grebely, Corey Markus, Louise Causer et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 37 citations

Public Affairs, Health Policy, Infectious Disease Control +10